MetaCap

LivaNova Earnings

NASDAQ: LIVNHealthcareMedical DevicesUSD

76.39+0.48 (+0.63%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$0.90

LivaNova earnings summary

LivaNova is scheduled to report Sep/2026 earnings on Nov 4, 2026 before the market opens, with analysts expecting EPS of $0.90. In its most recent report on Aug 5, 2026 (Q2 2026), LIVN posted EPS of $1.93. Revenue for the quarter was $390.6 million.

Quarterly EPS is up 286.0% from the same quarter a year earlier. Across the last 16 reports, LIVN shares moved an average of 5.6% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.

Summary generated from market data by MetaCap's automated system. Methodology

LIVN earnings history

LivaNova reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$1.93—+7.9%
May 6, 2026—$0.40—-2.6%
Feb 25, 2026—$0.57—-9.6%
Nov 5, 2025—$0.49—+9.7%
Aug 6, 2025—$0.50—+10.0%
May 7, 2025—$-6.01—+0.8%
Feb 25, 2025—$1.04—-5.9%
Oct 31, 2024—$0.60—+1.0%
Aug 1, 2024—$0.30—-6.4%
May 3, 2024—$-0.78—-3.2%
Feb 29, 2024—$0.30—-2.7%
Nov 1, 2023—$-0.14—-8.3%
Jul 26, 2023—$0.02—-1.2%
May 3, 2023—$0.14—-0.9%
Feb 27, 2023—$0.04—-10.9%
Nov 2, 2022—$-2.01—+8.8%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related